Avalo Therapeutics (C6K0.F) Q4 2025 Earnings

6NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-2.12
-1.46
-0.81
-0.16

Details

Expected EPS
-1.4357828465
Actual EPS
-1.8960800999999998
Surprise EPS
-0.46
Surprise Percent
+32.06%

Description

Avalo Therapeutics (C6K0.F) has reported earnings of -1.8960800999999998 per share for Q4 2025.

0 Comments

Share your thoughts